Clinical Trials in Philadelphia

Showing 4401-4420 of 20,904 trials

How Hormones and Exposure and Response Prevention (EX/RP) Affect the Brain of People With OCD

NCT05359562

Studies show that hormones affect the brain's fear extinction network, which is relevant for therapy involving exposure and response prevention (EX/RP), a first-line treatment for obsessive compulsive disorder (OCD). This study will examine the effect of delivering EX/RP to women during different phases in their menstrual cycle to determine the effects of hormones on the fear extinction network and on their OCD symptoms.

OCD

University of Pennsylvania120 participantsStarted Jun 2022

New York, New York, United States • Philadelphia, Pennsylvania, United States

RECRUITING< 1 mile

Genetics of Charcot Marie Tooth (CMT) - Modifiers of CMT1A, New Causes of CMT2

NCT01193088

This project includes two projects. One is looking for new genes that cause Charcot Marie Tooth disease (CMT). The other is looking for genes that do not cause CMT, but may modify the symptoms a person has.

Charcot-Marie-Tooth Disease, Type Ia (Disorder)HMSN

University of Iowa1,050 participantsStarted May 2010

Los Angeles, California, United States • Palo Alto, California, United States • Aurora, Colorado, United States +19 more locations

How Hormones and Exposure and Response Prevention (EX/RP) Affect the Brain of People With OCD

Genetics of Charcot Marie Tooth (CMT) - Modifiers of CMT1A, New Causes of CMT2

Find Trials by Condition in Philadelphia

Tasquinimod for the Treatment of Relapsed or Refractory Myeloma

Frespaciguat (MK-5475) INSIGNIA-PH-COPD: A Study of the Efficacy and Safety of Frespaciguat (an Inhaled sGC Stimulator) in Adults With PH-COPD

Parkinson's Disease and Movement Disorders Clinical Database

P-15L Bone Graft in Transforaminal Lumbar Interbody Fusion With Instrumentation

Lactobacillus Plantarum in Preventing Acute Graft Versus Host Disease in Children Undergoing Donor Stem Cell Transplant

African Cancer Genome: GMD

Open-label Extension Study of Enlicitide Decanoate (MK-0616/Enlicitide Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-019) CORALreef Extension

PDR001 Combination Therapy for Radioiodine-Refractory Thyroid Cancer

Post-Surgical Stereotactic Radiotherapy (SRT) Versus GammaTile-ROADS (Radiation One and Done Study)

Cognitive Remediation for Coordinated Specialty Care

Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)

Kaneka Endovascular Embolization and Protection

Improving Outcomes Assessment in Chronic GVHD

A Long-term Study Evaluating Hepatotoxicity Associated With TURALIO™ (Pexidartinib) Treatment

A Trial of Positively Smoke Free Group Therapy for HIV-infected Smokers

A Dose Response Study to Evaluate the Efficacy and Safety of Oral AP1189 Administered in Disease-Modifying Anti-Rheumatic Drug (DMARD) naïve Participants Participants With Early Rheumatoid Arthritis

Fractionated Docetaxel and Radium 223 in Metastatic Castration-Resistant Prostate Cancer

Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection